ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets
Founded more than 70 years ago, the Company has a network of manufacturing facilities and subsidiaries in North and South America, Europe, Asia and Oceania. We commercialise our products and services in all the major global markets and serve customers in over 50 countries.
We are a key supplier to the pharmaceutical industry providing a range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. We also supply excipients, cell culture media for diagnostics, GMP intermediates and research chemicals. Our services business provides contract manufacturing for solid and liquid finished dosage forms.
We manufacture and commercialise branded products in the pharmaceutical, nutraceutical and cosmetics markets.
Bile Acid Products
ICE Pharma is a specialist in bile acids and their derivatives
Founded more than 70 years ago, the company is now one of the main global players in bile-related products. Our global and integrated supply chain allows us to provide a unique range of bile acid products. The most important of which is Ursodeoxycholic acid (UDCA), a key active ingredient in drugs treating liver and gallbladder diseases. We produce a number of other bile acid APIs for which we have regulatory filings in the main markets.
Further important products in our range include cholic acid, deoxycholic acid, chenodeoxycholic acid, their salts and taurine and glycine conjugates. These find diverse uses from intermediates to excipients. Our long experience of manufacturing bile acids derivates allows us to meet the appropriate pharmaceutical quality standards.
Finished Dosage Forms
Our contract development and manufacturing services
Through our group company ABC Farmaceutici we offer services for every activity involved in the development and manufacturing of a pharma drug; from R&D trials up to the validation batches, including analytical development & validation, ICH stability studies, process development & validation, support for the regulatory filings and update of the e-CTD dossier. Manufacturing occurs at our state of the art facility which is fully GMP certified and operates to the highest quality standards.
Capsules prompt release
Capsule slow release
Tablets film coated
Syrups and Suspensions
Monodose drinkable vials
Our group company Dextra provides world leading innovative solutions for the total synthesis of challenging complex carbohydrates
From a few milligrams to multi kilogram scale we offer world-class expertise in oligosaccharide and chiral chemistry. We provide contract development services to take projects from discovery to clinical trial.
Our catalogue offers a comprehensive source of carbohydrate products, exploiting the complexity and diversity of glycobiology. We are a industrial supplier of N-Acetyl-D-mannosamine, a rare monosaccharide often used as a precursor in the chemical or enzymatic synthesis of the neuraminic acids found in glycolipids and glycoproteins.